Hikma Names Sandoz’ Genestin As New Generics BD Chief
As Sandoz Recruits From Teva To Replace Departing Head Of BD&L
Hikma has named Patrick Genestin as its new head of business development for generics, bringing to the role 25 years of experience that includes most recently a 15-year stint at Sandoz. In turn, Sandoz has looked to Teva for a successor.
